STRO — Sutro Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Sutro Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	118	368	198	334	376
Net Total Accounts Receivable
Net Total Receivables	6.3	5.56	12.5	7.12	36.1
Prepaid Expenses
Total Current Assets	129	378	219	353	422
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.63	12.9	51.6	51.1	44.8
Long Term Investments
Other Long Term Assets
Total Assets	156	394	341	407	471
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33	29.6	41.7	66.5	93.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	58.6	62.1	88.8	190	321
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	97.8	332	253	217	150
Total Liabilities & Shareholders' Equity	156	394	341	407	471
Total Common Shares Outstanding